MedTrace Logo

Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology

NCT00861224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2010-07-16

No results posted yet for this study

Summary

This study was conducted in conjunction with the 2 phase 3 studies of AMG 531 (20030105 and 20030212) and an open-label extension study (20030213) and compared pretreatment and posttreatment bone marrow samples for the purpose of studying morphologic changes.

Conditions

  • Idiopathic Thrombocytopenic Purpura

Interventions

OTHER

No Intervention for Observational Study

No intervention was used on this protocol, as this was an observational study.

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2006-10-31
Completion
2007-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861224 on ClinicalTrials.gov